Amphastar Pharmaceuticals (AMPH) Goodwill & Intangibles (2013 - 2026)

Amphastar Pharmaceuticals has reported Goodwill & Intangibles for 14 years, with the latest figure at $647.8 million in Q2 2026.

• On a quarterly basis, Goodwill & Intangibles rose 11.99% year-over-year to $647.8 million in Q2 2026; TTM through Jun 2026 was $647.8 million, a 11.99% increase from a year earlier, with the FY2025 full-year figure at $566.0 million, down 4.18% from the prior year.
• Goodwill & Intangibles was $647.8 million for Q2 2026 at Amphastar Pharmaceuticals, up from $559.6 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $647.8 million in Q2 2026, with the low at $37.0 million in Q3 2022.
• Average Goodwill & Intangibles over 5 years is $441.6 million, with a median of $581.5 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles decreased 5.87% in 2022, then soared 1572.25% in 2023.
• Over 5 years, Goodwill & Intangibles stood at $37.3 million in 2022, then jumped by 1544.31% to $613.3 million in 2023, then slipped by 3.69% to $590.7 million in 2024, then slipped by 4.18% to $566.0 million in 2025, then advanced by 14.47% to $647.8 million in 2026.
• The last three Goodwill & Intangibles figures came in at $647.8 million (Q2 2026), $559.6 million (Q1 2026), and $566.0 million (Q4 2025), per Business Quant data.